Apollomics, Inc. (APLM) vs Fractyl Health, Inc. (GUTS)
A side-by-side comparison of Apollomics, Inc. and Fractyl Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$22.70HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT
GUTS
Fractyl Health, Inc.
$4.45HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
Total return — APLM vs GUTS
growth of $100 · dividends reinvested · last 3yAPLM -71.3% (-34.0%/yr)GUTS -97.0% (-69.1%/yr)APLM compounded faster over this window
Log scale — wide-divergence pair
APLM GUTS
APLM vs GUTS: by the numbers
- •GUTS is the larger company ($59M vs $50M market cap).
- •Both run net losses; GUTS's is the smaller (0.00% vs -128.69% net margin).
Metrics side by side
Profitability
| Metric | APLM | GUTS |
|---|---|---|
| Gross margin | 97.00% | 0.00% |
| Operating margin | -111.45% | 0.00% |
| Net margin | -128.69% | 0.00% |
| ROIC | -2441.49% | -129.67% |
Growth (annualized)
| Metric | APLM | GUTS |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | N/A |
Go deeper
Dig into the metrics
Apollomics ROEFractyl Health ROEApollomics operating marginFractyl Health operating marginApollomics revenue growthFractyl Health revenue growthApollomics free cash flowFractyl Health free cash flow
Apollomics & Fractyl Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.